NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Copyright Public domain Remove constraint Copyright: Public domain Subjects Centers for Medicare & Medicaid Services (U.S.) Remove constraint Subjects: Centers for Medicare & Medicaid Services (U.S.)
Number of results to display per page

Search Results

1. Medicaid: CMS needs better data to monitor the provision of and spending on personal care services : report to Congressional requesters

nlm:nlmuid-101704049-pdf

2. Medicaid managed care: improved oversight needed of payment rates for long-term services and supports : report to Congressional requesters

nlm:nlmuid-101704057-pdf

4. Medicare provider education: oversight of efforts to reduce improper billing needs improvement : report to the Chairman, Committee on Finance, U.S. Senate

nlm:nlmuid-101713369-pdf

5. Medicaid program integrity: CMS should build on current oversight efforts by further enhancing collaboration with states : report to the Chairman, Committee on Finance, U.S. Senate

nlm:nlmuid-101713370-pdf

6. Health care: telehealth and remote patient monitoring use in Medicare and selected federal programs : report to Congressional committees

nlm:nlmuid-101713378-pdf

7. Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate

nlm:nlmuid-101713380-pdf

8. Medicare advantage: CMS should use data on disenrollment and beneficiary health status to strengthen oversight : report to Congressional Requesters

nlm:nlmuid-101713386-pdf

9. Medicaid personal care services: more harmonized program requirements and better data are needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

nlm:nlmuid-101713411-pdf

13. The role of ombudsmen in assuring quality for residents of long-term care facilities: straining to make ends meet

nlm:nlmuid-101527968-pdf

14. Hospital value-based purchasing: CMS should take steps to ensure lower quality hospitals do not qualify for bonuses : report to Congressional committees

nlm:nlmuid-101726983-pdf

15. Improper payments: improvements needed in CMS and IRS controls over health insurance premium tax credit : report to Congressional committees

nlm:nlmuid-101727023-pdf

16. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

nlm:nlmuid-101727033-pdf

17. Medicare: CMS should evaluate providing coverage for disposable medical devices that could substitute for durable medical equipment : report to Congressional committees

nlm:nlmuid-101727038-pdf

18. Medicare Advantage program integrity: CMS's efforts to ensure proper payments and identify and recover improper payments : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

nlm:nlmuid-101727106-pdf

19. Telehealth: use in Medicare and Medicaid : testimony before the Subcommittee on Agriculture, Energy, and Trade and Subcommittee on Health and Technology, Committee on Small Business, House of Representatives

nlm:nlmuid-101727108-pdf

20. Medicaid: states fund services for adults in institutions for mental disease using a variety of strategies : report to the Co-Chair, Caucus on International Narcotics Control, U.S. Senate

nlm:nlmuid-101727123-pdf

21. Health insurance marketplaces: CMS needs to improve its oversight of state IT systems' sustainability and performance : report to Congressional requesters

nlm:nlmuid-101727124-pdf

22. Medicaid managed care: CMS should improve oversight of access and quality in states' long-term services and supports programs : report to Congressional requesters

nlm:nlmuid-101727129-pdf

23. Medicare: CMS Fraud Prevention System uses claims analysis to address fraud : report to Congressional requesters

nlm:nlmuid-101727173-pdf

24. State health- insurance marketplaces: three states used varied data sources for eligibility and had few indications of potentially improper enrollments : report to Congressional requesters

nlm:nlmuid-101727205-pdf

25. Value-based coverage policy in the United States and the United Kingdom: different paths to a common goal

nlm:nlmuid-101317569-pdf

26. Health care price transparency and price competition

nlm:nlmuid-101317651-pdf

29. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff

nlm:nlmuid-101719990-pdf

30. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace

nlm:nlmuid-101737746-pdf

31. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

nlm:nlmuid-101737750-pdf

32. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

nlm:nlmuid-101737916-pdf

33. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS

nlm:nlmuid-101737930-pdf

34. A few states fell short in timely investigation of the most serious nursing home complaints: 2011-2015

nlm:nlmuid-101737931-pdf

35. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices

nlm:nlmuid-101737976-pdf

36. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data

nlm:nlmuid-101737978-pdf

37. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

nlm:nlmuid-101737981-pdf

38. Followup review: CMS's management of the quality payment program

nlm:nlmuid-101737984-pdf

39. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

nlm:nlmuid-101737986-pdf

40. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

nlm:nlmuid-101738059-pdf

41. Opioids in Ohio Medicaid: review of extreme use and prescribing

nlm:nlmuid-101738060-pdf

43. Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices

nlm:nlmuid-101738128-pdf

44. Questionable billing for compounded topical drugs in Medicare Part D

nlm:nlmuid-101738131-pdf

45. Medicare payments for clinical diagnostic laboratory tests in 2017: year 4 of baseline data

nlm:nlmuid-101738144-pdf

46. Medicare Advantage appeal outcomes and audit findings raise concerns about service and payment denials

nlm:nlmuid-101738161-pdf

47. States follow a common framework in responding to breaches of Medicaid data

nlm:nlmuid-101738172-pdf

48. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

nlm:nlmuid-101746114-pdf

49. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees

nlm:nlmuid-101746254-pdf

50. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters

nlm:nlmuid-101746260-pdf